Cargando…
Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression
Emerging evidence supports the pivotal roles of cancer-associated cachexia in breast cancer progression. However, the mediators and mechanisms that mediate cancer-induced cachexia remain unclear. Here, we show that breast cancer-derived exosomes alter adipocytes and muscle cells in terms of increase...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201501/ https://www.ncbi.nlm.nih.gov/pubmed/30359265 http://dx.doi.org/10.1186/s12943-018-0899-5 |
_version_ | 1783365515534663680 |
---|---|
author | Wu, Qi Sun, Si Li, Zhiyu Yang, Qian Li, Bei Zhu, Shan Wang, Lijun Wu, Juan Yuan, Jingping Yang, Changhua Li, Juanjuan Sun, Shengrong |
author_facet | Wu, Qi Sun, Si Li, Zhiyu Yang, Qian Li, Bei Zhu, Shan Wang, Lijun Wu, Juan Yuan, Jingping Yang, Changhua Li, Juanjuan Sun, Shengrong |
author_sort | Wu, Qi |
collection | PubMed |
description | Emerging evidence supports the pivotal roles of cancer-associated cachexia in breast cancer progression. However, the mediators and mechanisms that mediate cancer-induced cachexia remain unclear. Here, we show that breast cancer-derived exosomes alter adipocytes and muscle cells in terms of increased catabolism characterized by the release of metabolites. Likewise, tumour cells cocultivated with mature adipocytes or C2C12 exhibit an aggressive phenotype through inducing epithelial-mesenchymal transition. Mechanistically, we show that cancer cell-secreted miR-155 promotes beige/brown differentiation and remodel metabolism in resident adipocytes by downregulating the PPARγ expression, but does not significantly affect biological conversion in C2C12. In vitro the use of propranolol ameliorates tumour exosomes-associated cachectic wasting through upregulating the PPARγ expression. These results demonstrate that cancer-derived exosomes reprogram systemic energy metabolism and accelerate cancer-associated cachexia to facilitate tumour progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-018-0899-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6201501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-62015012018-10-31 Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression Wu, Qi Sun, Si Li, Zhiyu Yang, Qian Li, Bei Zhu, Shan Wang, Lijun Wu, Juan Yuan, Jingping Yang, Changhua Li, Juanjuan Sun, Shengrong Mol Cancer Letter to the Editor Emerging evidence supports the pivotal roles of cancer-associated cachexia in breast cancer progression. However, the mediators and mechanisms that mediate cancer-induced cachexia remain unclear. Here, we show that breast cancer-derived exosomes alter adipocytes and muscle cells in terms of increased catabolism characterized by the release of metabolites. Likewise, tumour cells cocultivated with mature adipocytes or C2C12 exhibit an aggressive phenotype through inducing epithelial-mesenchymal transition. Mechanistically, we show that cancer cell-secreted miR-155 promotes beige/brown differentiation and remodel metabolism in resident adipocytes by downregulating the PPARγ expression, but does not significantly affect biological conversion in C2C12. In vitro the use of propranolol ameliorates tumour exosomes-associated cachectic wasting through upregulating the PPARγ expression. These results demonstrate that cancer-derived exosomes reprogram systemic energy metabolism and accelerate cancer-associated cachexia to facilitate tumour progression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12943-018-0899-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-25 /pmc/articles/PMC6201501/ /pubmed/30359265 http://dx.doi.org/10.1186/s12943-018-0899-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to the Editor Wu, Qi Sun, Si Li, Zhiyu Yang, Qian Li, Bei Zhu, Shan Wang, Lijun Wu, Juan Yuan, Jingping Yang, Changhua Li, Juanjuan Sun, Shengrong Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression |
title | Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression |
title_full | Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression |
title_fullStr | Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression |
title_full_unstemmed | Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression |
title_short | Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression |
title_sort | tumour-originated exosomal mir-155 triggers cancer-associated cachexia to promote tumour progression |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201501/ https://www.ncbi.nlm.nih.gov/pubmed/30359265 http://dx.doi.org/10.1186/s12943-018-0899-5 |
work_keys_str_mv | AT wuqi tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT sunsi tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT lizhiyu tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT yangqian tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT libei tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT zhushan tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT wanglijun tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT wujuan tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT yuanjingping tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT yangchanghua tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT lijuanjuan tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression AT sunshengrong tumouroriginatedexosomalmir155triggerscancerassociatedcachexiatopromotetumourprogression |